Skip to main content

Table 2 Patient information

From: Construction of CD19 targeted dual- and enhanced dual-antibodies and their efficiency in the treatment of B cell malignancy

Patient ID

Disease

Sample type

CD19+CD10+ (%)

Patient1

ALL

BM

75

Patient2

ALL

BM

61.5

Patient3

ALL

BM

91.1

Patient4

ALL

BM

84.3

Patient5

ALL

BM

82.9

Patient6

ALL

BM

79.7

Back to article page

Experimental Hematology & Oncology

ISSN: 2162-3619

Contact us